Article Text

Download PDFPDF
Original research
Longer stent retrievers enhance thrombectomy performance in acute stroke
  1. Diogo C Haussen,
  2. Alhamza R Al-Bayati,
  3. Jonathan A Grossberg,
  4. Mehdi Bouslama,
  5. Clara Barreira,
  6. Nicolas Bianchi,
  7. Michael R Frankel,
  8. Raul G Nogueira
  1. Emory University/Marcus Stroke and Neuroscience Center-Grady Memorial Hospital, Atlanta, Florida, USA
  1. Correspondence to Dr Raul G Nogueira; raul.g.nogueira{at} and Dr Diogo C Haussen, Emory University/Marcus Stroke&Neuroscience Center-Grady Memorial Hospital, Atlanta, GA 30303, USA; diogo.haussen{at}


Background Longer stent retrievers have recently become available and have theoretical advantages over their shorter counterparts. We aim to evaluate whether stent retriever length impacts reperfusion rates in stroke thrombectomy.

Methods This was a retrospective analysis of a prospectively collected thrombectomy database in which equal diameter (4 mm) stent retrievers were used as the first-line strategy for intracranial internal carotid or middle cerebral artery M1 or M2 occlusions along with a balloon guide catheter from June 2011 to March 2017. The population was dichotomized into long (Trevo 4×30 mm/Solitaire 4×40 mm) or short (Trevo 4×20 mm/Solitaire 4×20 mm) retrievers. The primary outcome was first-pass modified Thrombolysis in Cerebral Infarction (mTICI) 2b/3 reperfusion.

Results Of 1126 thrombectomies performed within the study period, 420 were included. Age, gender, National Institutes of Health Stroke Scale, ASPECTS, IV tissue plasminogen activator use, stroke etiology, occlusion site, time from last-known-normal to puncture, distribution of Trevo and Solitaire, and the use of newer generation local thromboaspiration devices were comparable between the long and short retrievers. The short retriever group had more frequent hypertension, dyslipidemia, and atrial fibrillation. First-pass mTICI 2b/3 reperfusion was more common in the long retriever group (62% vs 50%; P=0.01). Parenchymal hematomas type 2, subarachnoid hemorrhage, 90-day modified Rankin Scale score 0–2, and mortality were comparable. Multivariable analysis indicated that long retriever (OR 2.2; 95% CI 1.3 to 3.6; P=0.001), radiopaque device (OR 2.1; 95% CI 1.2 to 3.4; P=0.003), and adjuvant local aspiration (OR 2.4; 95% CI 1.3 to 4.3; P=0.003) were independently associated with first-pass reperfusion.

Conclusions The use of longer stent retrievers is an independent predictor of first-pass mTICI 2b/3 reperfusion. First-pass reperfusion was also associated with the use of radiopaque devices and adjuvant local aspiration.

  • thrombectomy
  • stroke

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Contributors DCH: Study conception, design of the work, acquisition of data, statistical analysis, interpretation of data, drafting of the manuscript. ARA-B: Data acquisition, critical revision of manuscript. JAG: Data acquisition, critical revision of manuscript. MB: Data acquisition, critical revision of manuscript. CB: Data acquisition, critical revision of manuscript. NB: Critical revision of manuscript. MRF: Critical revision of manuscript. RGN: Design of the work, acquisition of data, interpretation of data, critical revision of manuscript. All authors gave final approval of the version to be published, and are in agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests RGN: Stryker-Neurovacular (Trevo-2 and DAWN/Trial PI), Covidien (SWIFT and SWIFT-PRIME/Steering- Committee, STAR Trial/Core-Lab), Penumbra (3-D Separator Trial/Executive-Committee).

  • Patient consent Not required.

  • Ethics approval Emory University IRB.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data sharing statement The unpublished data from this dataset is held by Grady Memorial Hospital/Emory University and DCH/RGN. Requests for data sharing would be required to be discussed with them directly.